Abiopharma

News list

Irie Shuji 🟢 acquired 37.4K shares (1 derivative) of ORIX CORP (IX) Transaction Date: Jun 25, 2026 | Filing ID: 281792

Full text

News bot June 25, 2026, 10:32 a.m.
🔍 Irie Shuji (Executive)

Company: ORIX CORP (IX)

Report Date: 2026-06-25
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 37,370
Detailed Transactions and Holdings:
- Acquired 37,370 shares of Share-based Compensation Points (Derivative)
  Date: 2026-06-23 | Code: J | equity_swap_involved: false | shares_owned_after: 52,940.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each point represents a right to receive one share of Common Stock.
- F2: The reported derivative securities represent share-based compensation granted under ORIX Corporation's share-based compensation program, which entitles the Reporting Person to receive the stated amount of Common Stock upon retirement.
- REMARKS: Senior Managing Executive Officer Chief Operating Officer, Infrastructure Business Unit